Home / Import refusals / 8GQ-0058168-5/21/2I

FDA Import Refusal 8GQ-0058168-5/21/2I — Pharmaster +

Pharmaster + — FEI 3006627937

The FDA refused shipment 8GQ-0058168-5/21/2I from Pharmaster + (France) on June 24, 2024. The refused product falls under Drugs and Biologics — NAPHAZOLINE HCL (ADRENERGIC). Cited charges: 118,3280 This firm has 5 or more other import refusals on record.

Refusal Details

Date
June 24, 2024
Country
France
Product Category
Drugs and Biologics
Product Code
60CBL46 NAPHAZOLINE HCL (ADRENERGIC)
Charges
118,3280

Recent inspections

  • 1233645 (VAI Fri Apr 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • SCS-9816462-1/11/1 (Tue May 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-6248466-6/11/1 (Fri Oct 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-5477552-1/11/1 (Fri Aug 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-5477618-0/11/1 (Fri Aug 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-3624116-7/11/1 (Wed Sep 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources